
BioDelivera unveils GCV platform to target only diseased cells
Two UT Dallas-trained sisters in Y Combinator's Fall 2026 batch say their programmable vehicle can deliver genetic medicines to tumors, muscle and brain. The evidence is still early.
We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.
